HCPs see biosimilars as solution to tackle rising costs: GlobalData
Across surveyed countries, China had the highest percentage of physicians (92 per cent) who believed that the use of biosimilars…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biosimilars
Samsung Biologics partners with Pfizer for manufacturing of biosimilars portfolio
Under the terms of the new agreement, Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing…
Eminence Business Media hosts sixth edition of Annual Pharma Project & Portfolio Management…
The programme comprised various discussion topics for project and portfolio management teams through interactive sessions and…
Sandoz partners with Just–Evotec Biologics to develop and manufacture multiple biosimilars
Sandoz recently signed a MoU to build a new biologics production plant in Slovenia – an expected investment of at least $400…
Teva and Sandoz make major push to biosimilars
Executives from Teva and Sandoz said they are targetting top-selling biologics such as Humira, AbbVie Inc’s top-selling arthritis…
Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables
The drug major also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further…
Biocon Biologics to acquire Viatris’ biosimilars assets for up to $3.335 billion
Viatris to provide commercial and other transition services for an expected period of two years to ensure continuity of customer…
CPhI and Informa Pharma Intelligence conclude 3rd Biopharma Conclave
The conclave drew insights on biologics, cell and gene therapy, vaccines and biosimilars
A Superstar marriage?
Chandru Chawla, a pharma veteran, opines that Biocon and SII coming together is a milestone event in the evolution of Indian…
Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData
On March 2, 2021, Cipla Gulf and Alvotech expanded their partnership to market and distribute four biosimilars; aflibercept…